Full Approval Granted to MET Inhibitor for Lung Cancer
The FDA has granted full approval to tepotinib for some non-small cell lung cancers that harbor a certain mutation in the MET gene. The U.S. Food and Drug Administration (FDA) has approved tepotinib (Tepmetko)...